Covid-19, Critical Illness
Conditions
Brief summary
The study will prospectively collect data from patients with Covid-19 admitted to the Västerås Intensive Care Unit, Västerås Hospital. Demographic, clinical, radiographic and laboratory characteristics will be recorded. Analysis of data to identify predictors of disease severity, mortality and treatment response.
Interventions
Not required
Sponsors
Study design
Eligibility
Inclusion criteria
* Patients admitted to the Intensive Care Unit with biological samples positive for SARS-CoV-2. * Patients admitted to the Intensive Care Unit with one or more negative tests but with clinical and radiological characteristics highly suggestive of SARS-CoV-2 and thus considered positive for the disease.
Exclusion criteria
* None.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| All-cause mortality | At 90 days follow-up after admittance to Intensive Care |
Secondary
| Measure | Time frame |
|---|---|
| ICU length of stay | Until 90 days after admittance to Intensive Care |
| Number of days on mechanical ventilation | Until 90 days after admittance to Intensive Care |
| Hospital length of stay | Until 90 days after admittance to Intensive Care |
| Number of patients receiving renal replacement therapy | Until 90 days after admittance to Intensive Care |
| Patient characteristics | At admission to ICU |
| Number of patients receiving vasopressor support | Until 90 days after admittance to Intensive Care |
Countries
Sweden